Melanie Eugenio-Simoes
Rennes, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Trim21 deficiency in mice increases HCC carcinogenesis in a NASH context and is associated with immune checkpoint upregulation.
Journal: International journal of cancer
Published: July 12, 2023
A Transversal Approach Combining In Silico, In Vitro and In Vivo Models to Describe the Metabolism of the Receptor Interacting Protein 1 Kinase Inhibitor Sibiriline.
Journal: Pharmaceutics
Published: October 17, 2022
Betulin, a Newly Characterized Compound in Acacia auriculiformis Bark, Is a Multi-Target Protein Kinase Inhibitor.
Journal: Molecules (Basel, Switzerland)
Published: June 02, 2021
Receptor-interacting protein kinase-1 ablation in liver parenchymal cells promotes liver fibrosis in murine NASH without affecting other symptoms.
Journal: Journal of molecular medicine (Berlin, Germany)
Published: April 08, 2021
TRIM21, a New Component of the TRAIL-Induced Endogenous Necrosome Complex.
Journal: Frontiers in molecular biosciences
Published: December 22, 2020
Hepatocellular Carcinoma Emergence in Diabetic Mice with Non-Alcoholic Steatohepatitis Depends on Diet and Is Delayed in Liver Exhibiting an Active Immune Response.
Journal: Cancers
Published: April 14, 2020
Depletion of RIPK1 in hepatocytes exacerbates liver damage in fulminant viral hepatitis.
Journal: Cell death & disease
Published: July 31, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026